Table 2.

The treatment details

TreatmentDetailsn = 76
Lipid-lowering therapyStatin61 of 76 (80.3%)
Fibrateone of 76 (1.3%)
Ezetimibetwo of 76 (2.6%)
SHARP trialone of 76 (1.3%)
Total65 of 76 (85.5%)
AngiographyMonoplane30 of 76 (39.5%)
Biplane46 of 76 (60.5%)
Mean volume of contrast (ml)55.74 ± 50.18
RevascularizationPercutaneous (Unstaged)2 of 76 (2.6%)
Percutaneous (Staged)11 of 76 (%)
Surgical (CABG)10 of 76 (13.2%)
Total23 of 76 (30.3%)
  • CABG, coronary artery by-pass graft.